Crossref
S4-5 RevMate®に基づくレナリドミド後発品の安全対策の現状と課題
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku · 2025 · 30 (Supplement) · S109-S109
DOI: 10.3820/jjpe.30.s109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku, 2025. Verfasst von 泉 吾妻.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
吾妻, 泉. (2025). S4-5 RevMate®に基づくレナリドミド後発品の安全対策の現状と課題. Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku, 30(Supplement), S109-S109. https://doi.org/10.3820/jjpe.30.s109
Vancouver
吾妻 泉. S4-5 RevMate®に基づくレナリドミド後発品の安全対策の現状と課題. Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku. 2025;30(Supplement):S109-S109. doi:10.3820/jjpe.30.s109
BibTeX
@article{2025,
author = {吾妻, 泉},
title = {S4-5 RevMate®に基づくレナリドミド後発品の安全対策の現状と課題},
journal = {Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku},
year = {2025},
volume = {30},
number = {Supplement},
pages = {S109--S109},
doi = {10.3820/jjpe.30.s109}
}
EUVIMED